Farmaforum Partnering Day 2026

23 Sept 2026 | Madrid, Spain

Register
Register
Register

InvestmentUpdated on 18 June 2026

Investment opportunity in cannabis medicines for addiction treatment

CEO at MEDICAL FLOWERS DEVELOPMENTS

MADRID, Spain

About

MFD is preparing the clinical validation of a new generation of cannabis medicated chewing gums designed to support behavioural therapies in addiction treatment.

The first clinical program focuses on Cannabis Use Disorder (CUD), an unmet medical need with no approved pharmacological treatment today.

The product is conceived as a pharmaceutical-grade, single-dose oral dosage form with controlled delivery through the buccal mucosa. Its objective is to help manage anxiety peaks and craving during addiction treatment processes.

MFD is seeking biotech, pharma and health innovation investors to support its next value-inflection stage: Phase I clinical validation, regulatory development and preparation for future clinical expansion into other addiction-related indications, including alcohol, cocaine and opioid dependence.

Stage

  • Seed and Development

Applies to

  • Healthcare

Organisation

Similar opportunities